Cancer molecular markers: A guide to cancer detection and management
Cancer is generally caused by the molecular alterations which lead to specific mutations.
Advances in molecular biology have provided an impetus to the study of cancers with …
Advances in molecular biology have provided an impetus to the study of cancers with …
Approach to the thyroid cancer patient with bone metastases
JA Wexler - The Journal of Clinical Endocrinology & Metabolism, 2011 - academic.oup.com
Thyroid cancer incidence has been increasing for de-cades in the United States (1, 2). There
are known risk factors for thyroid cancer including female gender, advancing age, family …
are known risk factors for thyroid cancer including female gender, advancing age, family …
Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway
J Zhou, L Xia, Y Zhang - Pathology-Research and Practice, 2019 - Elsevier
The present study aimed to investigate the anti-tumor effects of naringin in thyroid cancer
(TC), and to explore the underlying mechanisms. TC cell lines TPC-1 and SW1736 were …
(TC), and to explore the underlying mechanisms. TC cell lines TPC-1 and SW1736 were …
Influence of cigarette smoking on thyroid gland—an update
N Sawicka-Gutaj, P Gutaj, J Sowiński… - Endokrynologia …, 2014 - journals.viamedica.pl
Many studies have shown that cigarette smoking exerts multiple effects on the thyroid gland.
Smoking seems to induce changes in thyroid function tests, like decrease in TSH and …
Smoking seems to induce changes in thyroid function tests, like decrease in TSH and …
Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer
M Zane, M Agostini, MV Enzo, EC Ide… - Biomedicine & …, 2013 - Elsevier
Purpose In the latest years, high levels of circulating cell-free DNA (cf-DNA) have been
found to be associated with cancer diagnosis and progression, and cf-DNA has become a …
found to be associated with cancer diagnosis and progression, and cf-DNA has become a …
The role of miRNA in papillary thyroid cancer in the context of miRNA Let-7 family
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. RET/PTC
rearrangement is the most common genetic modification identified in this category of cancer …
rearrangement is the most common genetic modification identified in this category of cancer …
Omics sciences and precision medicine in thyroid cancer
K Dhuli, MC Medori, K Donato, PE Maltese… - La Clinica …, 2023 - ricerca.unich.it
Background: Thyroid cancer, a heterogeneous disease originating from the thyroid gland,
stands as the predominant endocrine malignan-cy worldwide. Despite advances in …
stands as the predominant endocrine malignan-cy worldwide. Despite advances in …
[HTML][HTML] Matrine inhibits TPC‑1 human thyroid cancer cells via the miR‑21/PTEN/Akt pathway
L Zhao, X Zhang, S Cui - Oncology Letters, 2018 - spandidos-publications.com
Papillary thyroid cancer (PTC) is the primary type of thyroid cancer and the most widespread
endocrine malignancy. Matrine is a traditional Chinese medicine and has been …
endocrine malignancy. Matrine is a traditional Chinese medicine and has been …
Detection of PAX8/PPARG and RET/PTC Rearrangements Is Feasible in Routine Air-Dried Fine Needle Aspiration Smears
C Ferraz, C Rehfeld, A Krogdahl, EM Precht Jensen… - Thyroid, 2012 - liebertpub.com
Background: The diagnostic limitations of fine needle aspiration (FNA), like the
indeterminate category, can be partially overcome by molecular analysis. As PAX8/PPARG …
indeterminate category, can be partially overcome by molecular analysis. As PAX8/PPARG …
Sorafenib for the treatment of thyroid cancer: an updated review
J Krajewska, D Handkiewicz-Junak… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: Sorafenib (Nexavar) is an oral multi-kinase inhibitor targeting B-type Raf kinase
(BRAF)(both wild type and BRAFV600E), VEGFR1, VEGFR2, VEGFR3, PDGFRβ and RET …
(BRAF)(both wild type and BRAFV600E), VEGFR1, VEGFR2, VEGFR3, PDGFRβ and RET …